SCHEMBL19348305

SCHEMBL19348305

Cc1n[nH]c2ccc(-c3cncc4c3COCC4N)cc12

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
JAK2 O60674 4/20 0.36
DYRK1A Q13627 2/20 0.36
CLK2 P49760 1/20 0.36
CLK3 P49761 1/20 0.36
CYP11B1 P15538 4/20 0.35
CYP11B2 P19099 4/20 0.35
GSK3B P49841 3/20 0.35
KCNH2 Q12809 3/20 0.35
WNT1 P04628 3/20 0.34
JAK1 P23458 1/20 0.33
TYK2 P29597 1/20 0.33
JAK3 P52333 1/20 0.33
MAP3K8 P41279 1/20 0.33
LRRK2 Q5S007 2/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19348314 0.92 PRMT5 (0.37) PRMT5WDR77JAK2CYP11B1CYP11B2
SCHEMBL17814209 0.88 CYP11B1 (0.36) PRMT5WDR77JAK2DYRK1ACLK2
SCHEMBL21105114 0.81 MAP3K8 (0.35) PRMT5WDR77DYRK1ACYP11B1CYP11B2
SCHEMBL19348316 0.81 CCNC (0.35) PRMT5WDR77JAK2CYP11B1CYP11B2
SCHEMBL17814133 0.81 CYP11B2 (0.47) PRMT5WDR77JAK2DYRK1ACLK2
SCHEMBL17814210 0.80 CYP11B1 (0.36) PRMT5WDR77JAK2CYP11B1CYP11B2
SCHEMBL19348326 0.80 MAPK14 (0.41) PRMT5WDR77CYP11B1CYP11B2
SCHEMBL17814137 0.79 CYP11B2 (0.51) CYP11B1CYP11B2
SCHEMBL21105091 0.79 CYP11B2 (0.35) PRMT5WDR77DYRK1ACYP11B1CYP11B2
SCHEMBL21105221 0.76 PRMT5 (0.34) PRMT5WDR77CYP11B1CYP11B2MAP3K8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227300-B1 ALDOSTERONE SYNTHASE INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2019-06-19 EP disclosed
US-9890171-B2 Aldosterone synthase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-02-13 US disclosed
US-20170267688-A1 ALDOSTERONE SYNTHASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267688-A1 ALDOSTERONE SYNTHASE INHIBITORS CYP11B1, CYP21A2, CYP11B2 PRMT5 989/4885WDR77 2519/4885JAK2 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.